Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Currently available intravenous immunoglobulin contains antibodies reacting against severe acute respiratory syndrome coronavirus 2 antigens
Authors
Keywords
-
Journal
Immunotherapy
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2020-05-13
DOI
10.2217/imt-2020-0095
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Is COVID-19 receiving ADE from other coronaviruses?
- (2020) Jason A. Tetro MICROBES AND INFECTION
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
- (2020) Li Guo et al. CLINICAL INFECTIOUS DISEASES
- Strategies for the prevention and management of coronavirus disease 2019
- (2020) Wei-jie Guan et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
- (2020) Annarosa Soresina et al. PEDIATRIC ALLERGY AND IMMUNOLOGY
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
- (2020) Wei Cao et al. Open Forum Infectious Diseases
- Use of human immunoglobulins as an anti-infective treatment: the experience so far and their possible re-emerging role
- (2017) Jordi Bozzo et al. Expert Review of Anti-Infective Therapy
- Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests
- (2013) Kwok-Hung Chan et al. JOURNAL OF INFECTION
- Anti-inflammatory effects of high-dose IgG on TNF-α-activated human coronary artery endothelial cells
- (2012) Akio Matsuda et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Intravenous immunoglobulin modulates the maturation of TLR 4-primed peripheral blood monocytes
- (2011) Mark Ballow et al. CLINICAL IMMUNOLOGY
- Intravenous immunoglobulin G (IVIG) inhibits IL-1- and TNF-α-dependent, but not chemotactic-factor-stimulated, neutrophil transendothelial migration
- (2011) Andrew C. Issekutz et al. CLINICAL IMMUNOLOGY
- Mechanisms of action of immune globulin
- (2009) E. Fernández-Cruz et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Intravenous Immunoglobulin a Natural Regulator of Immunity and Inflammation
- (2009) Stanley C. Jordan et al. TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started